D-1152-2014 Class III Terminated

Recalled by Fougera Pharmaceuticals Inc. — Melville, NY

FDA drug recall D-1152-2014 was initiated by Fougera Pharmaceuticals Inc. on Jan 29, 2014 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%. The recall status is terminated (terminated Dec 8, 2015). Affected quantity: 493,192 tubes.

Recall details

Product Type
Drugs
Report Date
Mar 19, 2014
Initiation Date
Jan 29, 2014
Termination Date
Dec 8, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
493,192 tubes

Product description

Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0004-80, UPC 3 0168-0004-80 8.

Reason for recall

Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.

Distribution pattern

Nationwide.

Code information

Lot #: 485P, 486P, 487P, 488P, Exp 06/15; 638P, 639P, 640P, Exp 07/15; 753P, 754P, 755P, Exp 08/15; 898P, 756P, 757P, 758P, 899P, 900P, 901P, 902P, Exp 09/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1152-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1152-2014. Report a data issue: hello@regdatalab.com.